ASCO 2019 | POLO: Olaparib as maintenance treatment for metastatic prostate cancer

Michael Hall

Michael Hall, MD, MS of the Fox Chase Cancer Center, Philadelphia, PA, talks on the key updates from the POLO trial investigating olaparib as maintenance treatment for metastatic pancreatic cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics